Fully underwritten rights issue rights issue in Observe Medical ASA (NO) — NOK 180 million Healthcare Fully underwritten rights issue rights issue in Observe Medical ASA (NO) — NOK 180 million
Sale of Active Brands to FSN Capital Partners and Verdane – Amount not disclosed Consumer & Retail Sale of Active Brands to FSN Capital Partners and Verdane – Amount not disclosed
Private placement in Heroic Group AS (NO) — NOK 60 million TMT Private placement in Heroic Group AS (NO) — NOK 60 million
Initial public offering of Vår Energi (NO) on Oslo Stock Exchange – NOK 8.9 billion Cleantech, Renewables & Infrastructure Initial public offering of Vår Energi (NO) on Oslo Stock Exchange – NOK 8.9 billion
Directed new share issue in Hexagon Purus (NO) — NOK 600 million Cleantech, Renewables & Infrastructure Directed new share issue in Hexagon Purus (NO) — NOK 600 million
Private placement in Hjemmelegene AS (NO) — NOK 70 million Healthcare Private placement in Hjemmelegene AS (NO) — NOK 70 million
Private placement in Cytovation ASA (NO) — NOK 180 million Healthcare Private placement in Cytovation ASA (NO) — NOK 180 million
Senior secured bond issue by Fibo Group AS (NO) – NOK 500 million Business Services Senior secured bond issue by Fibo Group AS (NO) – NOK 500 million
Directed new share issue in Nordic Nanovector ASA (NO) — NOK 250 million Healthcare Directed new share issue in Nordic Nanovector ASA (NO) — NOK 250 million
Rights issue in Targovax ASA (NO) — NOK 175 million Healthcare Rights issue in Targovax ASA (NO) — NOK 175 million
Rights issue in Flyr AS (NO) — NOK 250 million Business Services Rights issue in Flyr AS (NO) — NOK 250 million
Acquisition of Medrave Software AB (SE) by Carasent ASA (NO) — SEK 125 million Healthcare Acquisition of Medrave Software AB (SE) by Carasent ASA (NO) — SEK 125 million